Workshop on Future Opportunities for
Combination Biological Therapy of Cancer
November 1, 2007
Seaport World Trade Center
Boston, Massachusetts
Abstract Submission: May 1 - July 23
Submit Abstract Now
Abstract submission begins online via the iSBTc website at 12:00 pm CT (noon) on Tuesday, May 1 and runs through 12:00 pm CT (noon) on Monday, July 23. Abstracts submitted by the deadline are reviewed by a committee for selection of poster and/or oral presentation. Accepted abstracts will be published in the Journal of Immunotherapy, the official journal of iSBTc. There are no fees for abstract submission and both iSBTc members and non-members are encouraged to submit their abstracts for review. Young investigators submitting abstracts may be eligible for travel awards.
Abstract Topics:
- Angiogenesis and Vascular Therapies
- Cellular Therapies
- Characterizing the Host Response to Cancer
- Combination Therapy for Cancer*
- Immunoregulation and Mediated Tolerance
- Inflammation and Innate Immunity
- New Agents
- Tumor Microenvironment
- Tumor Recognition / Immune Evasion
- Vaccines / Dendritic Cells
* Abstracts submitted in this category are eligible for oral presentation at the Thursday Workshop on Future Opportunities for Combination Biological Therapy of Cancer. Abstracts not selected for oral presentation will be offered the opportunity to present a poster in the Friday and Saturday poster presentation sessions and may be eligible for the Young Investigator Travel Awards.
|